These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7582706)

  • 41. Purine enzymes in patients with rheumatoid arthritis treated with methotrexate.
    van Ede AE; Laan RF; De Abreu RA; Stegeman AB; van de Putte LB
    Ann Rheum Dis; 2002 Dec; 61(12):1060-4. PubMed ID: 12429535
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Case report: RAEB in a patient with rheumatoid arthritis treated with methotrexate and infliximab].
    D'Alessandro G; Bianco MR; Politis S; Ferrandina C; Rossi G; Altomare E
    Reumatismo; 2006; 58(1):59-61. PubMed ID: 16639489
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Usefulness of daily folic acid supplementation during methotrexate treatment of Japanese patients with rheumatoid arthritis.
    Sasaki K; Tsuji T; Kimoto Y; Yanagihara Y; Masuguchi K; Chikamori A; Watanabe H; Murakami T; Oryoji D; Hashimoto M; Horiuchi T; Egashira N
    Mod Rheumatol; 2021 Jan; 31(1):108-113. PubMed ID: 32167789
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Folic acid supplementation for rheumatoid arthritis patients on methotrexate: the good gets better.
    Singh JA
    Cochrane Database Syst Rev; 2013 Jul; 2013(7):ED000063. PubMed ID: 24151647
    [No Abstract]   [Full Text] [Related]  

  • 45. Disease remission and sustained halting of radiographic progression with combination etanercept and methotrexate in patients with rheumatoid arthritis.
    van der Heijde D; Klareskog L; Landewé R; Bruyn GA; Cantagrel A; Durez P; Herrero-Beaumont G; Molad Y; Codreanu C; Valentini G; Zahora R; Pedersen R; MacPeek D; Wajdula J; Fatenejad S
    Arthritis Rheum; 2007 Dec; 56(12):3928-39. PubMed ID: 18050208
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genotoxicity assessment using micronuclei assay in rheumatoid arthritis patients.
    Ramos-Remus C; Dorazco-Barragan G; Aceves-Avila FJ; Alcaraz-Lopez F; Fuentes-Ramirez F; Michel-Diaz J; Torres-Bugarin O; Ventura-Aguilar A; Zuñiga-González G
    Clin Exp Rheumatol; 2002; 20(2):208-12. PubMed ID: 12051400
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Patient reported outcomes in a trial of combination therapy with etanercept and methotrexate for rheumatoid arthritis: the TEMPO trial.
    van der Heijde D; Klareskog L; Singh A; Tornero J; Melo-Gomes J; Codreanu C; Pedersen R; Freundlich B; Fatenejad S
    Ann Rheum Dis; 2006 Mar; 65(3):328-34. PubMed ID: 16079172
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cyclosporin A monotherapy versus cyclosporin A and methotrexate combination therapy in patients with early rheumatoid arthritis: a double blind randomised placebo controlled trial.
    Gerards AH; Landewé RB; Prins AP; Bruyn GA; Goei Thé HS; Laan RF; Dijkmans BA
    Ann Rheum Dis; 2003 Apr; 62(4):291-6. PubMed ID: 12634224
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Folic acid supplementation during methotrexate treatment: nonsense?
    Manna R; Verrecchia E; Diaco M; Montalto M; Cammarota G; Gasbarrini G
    Rheumatology (Oxford); 2005 Apr; 44(4):563-4. PubMed ID: 15657069
    [No Abstract]   [Full Text] [Related]  

  • 50. Comparative study of intramuscular gold and methotrexate in a rheumatoid arthritis population from a socially deprived area.
    Hamilton J; McInnes IB; Thomson EA; Porter D; Hunter JA; Madhok R; Capell HA
    Ann Rheum Dis; 2001 Jun; 60(6):566-72. PubMed ID: 11350844
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tocilizumab inhibits structural joint damage and improves physical function in patients with rheumatoid arthritis and inadequate responses to methotrexate: LITHE study 2-year results.
    Fleischmann RM; Halland AM; Brzosko M; Burgos-Vargas R; Mela C; Vernon E; Kremer JM
    J Rheumatol; 2013 Feb; 40(2):113-26. PubMed ID: 23322466
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy and safety of methotrexate in combination with other non-biologic disease-modifying antirheumatic drugs (DMARDs) in treatment of rheumatoid arthritis.
    Castrejón I; Gibson KA; Pincus T
    Bull Hosp Jt Dis (2013); 2013; 71 Suppl 1():S20-8. PubMed ID: 24219037
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Longterm efficacy and safety of abatacept in patients with rheumatoid arthritis treated in routine clinical practice: effect of concomitant methotrexate after 24 weeks.
    Takahashi N; Kojima T; Kaneko A; Kida D; Hirano Y; Fujibayashi T; Yabe Y; Takagi H; Oguchi T; Miyake H; Kato T; Watanabe T; Hayashi M; Kanayama Y; Funahashi K; Asai S; Yoshioka Y; Takemoto T; Terabe K; Asai N; Ishiguro N
    J Rheumatol; 2015 May; 42(5):786-93. PubMed ID: 25834204
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adverse events in methotrexate-treated rheumatoid arthritis patients.
    Sandoval DM; Alarcón GS; Morgan SL
    Br J Rheumatol; 1995 Nov; 34 Suppl 2():49-56. PubMed ID: 8535650
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Therapies for active rheumatoid arthritis after methotrexate failure.
    O'Dell JR; Mikuls TR; Taylor TH; Ahluwalia V; Brophy M; Warren SR; Lew RA; Cannella AC; Kunkel G; Phibbs CS; Anis AH; Leatherman S; Keystone E;
    N Engl J Med; 2013 Jul; 369(4):307-18. PubMed ID: 23755969
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Safety and efficacy of combination therapy of iguratimod with methotrexate for patients with active rheumatoid arthritis with an inadequate response to methotrexate: an open-label extension of a randomized, double-blind, placebo-controlled trial.
    Hara M; Ishiguro N; Katayama K; Kondo M; Sumida T; Mimori T; Soen S; Nagai K; Yamaguchi T; Yamamoto K;
    Mod Rheumatol; 2014 May; 24(3):410-8. PubMed ID: 24252050
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Reducing toxicity of methotrexate with folic acid].
    Harten P
    Z Rheumatol; 2005 Jun; 64(5):353-8. PubMed ID: 15965822
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Combination treatment of rheumatoid arthritis with cyclosporine and methotrexate.
    Stein CM; Pincus T
    Clin Exp Rheumatol; 1999; 17(6 Suppl 18):S47-52. PubMed ID: 10589357
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Update on methotrexate as the anchor drug for rheumatoid arthritis.
    Pincus T; Gibson KA; Castrejón I
    Bull Hosp Jt Dis (2013); 2013; 71 Suppl 1():S9-19. PubMed ID: 24219036
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use.
    Proudman SM; Keen HI; Stamp LK; Lee AT; Goldblatt F; Ayres OC; Rischmueller M; James MJ; Hill CL; Caughey GE; Cleland LG
    Semin Arthritis Rheum; 2007 Oct; 37(2):99-111. PubMed ID: 17391739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.